| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 426 | 2024 |
| Development and validation of an endoscopic images‐based deep learning model for detection with nasopharyngeal malignancies C Li, B Jing, L Ke, B Li, W Xia, C He, C Qian, C Zhao, H Mai, M Chen, ... Cancer Communications 38 (1), 1-11, 2018 | 86 | 2018 |
| Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma … X Lv, X Cao, WX Xia, KY Liu, MY Qiang, L Guo, CN Qian, KJ Cao, HY Mo, ... The Lancet Oncology 22 (5), 716-726, 2021 | 64 | 2021 |
| Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma C An, D Li, S Li, W Li, T Tong, L Liu, D Jiang, L Jiang, G Ruan, N Hai, Y Fu, ... European journal of nuclear medicine and molecular imaging, 1-13, 2022 | 52 | 2022 |
| Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis C An, WZ Li, ZM Huang, XL Yu, YZ Han, FY Liu, SS Wu, J Yu, P Liang, ... European Radiology 31, 4764-4773, 2021 | 51 | 2021 |
| The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling WZ Qiu, HB Zhang, WX Xia, LR Ke, J Yang, YH Yu, H Liang, XJ Huang, ... Journal of Experimental & Clinical Cancer Research 37, 1-17, 2018 | 45 | 2018 |
| The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma Y Yu, L Ke, X Lv, YH Ling, J Lu, H Liang, W Qiu, X Huang, G Liu, W Li, ... Cancer Management and Research, 1935-1946, 2018 | 43 | 2018 |
| Effect of induction chemotherapy with paclitaxel, cisplatin, and capecitabine vs cisplatin and fluorouracil on failure-free survival for patients with stage IVA to IVB … WZ Li, X Lv, D Hu, SH Lv, GY Liu, H Liang, YF Ye, W Yang, HX Zhang, ... JAMA oncology 8 (5), 706-714, 2022 | 38 | 2022 |
| Development of a prognostic model to identify the suitable definitive radiation therapy candidates in de novo metastatic nasopharyngeal carcinoma: a real-world study WZ Li, SH Lv, GY Liu, H Liang, X Guo, X Lv, KY Liu, MY Qiang, X Chen, ... International Journal of Radiation Oncology* Biology* Physics 109 (1), 120-130, 2021 | 38 | 2021 |
| Effect of capecitabine maintenance therapy plus best supportive care vs best supportive care alone on progression-free survival among patients with newly diagnosed metastatic … GY Liu, WZ Li, DS Wang, H Liang, X Lv, YF Ye, C Zhao, LR Ke, SH Lv, ... JAMA oncology 8 (4), 553-561, 2022 | 36 | 2022 |
| Immune checkpoint inhibitor associated hepatotoxicity in primary liver cancer versus other cancers: a systematic review and meta‐analysis J Fu, WZ Li, NA McGrath, CW Lai, G Brar, YQ Xiang, C Xie Frontiers in oncology 11, 650292, 2021 | 35 | 2021 |
| Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score … GY Liu, X Lv, YS Wu, MJ Mao, YF Ye, YH Yu, H Liang, J Yang, LR Ke, ... Cancer Communications 38 (1), 1-10, 2018 | 35 | 2018 |
| Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival WZ Li, SH Lv, GY Liu, H Liang, WX Xia, YQ Xiang Biology of sex Differences 12, 1-10, 2021 | 31 | 2021 |
| Assessment of survival model performance following inclusion of Epstein-Barr virus DNA status in conventional TNM staging groups in Epstein-Barr virus–related nasopharyngeal … WZ Li, HJ Wu, SH Lv, XF Hu, H Liang, GY Liu, N Lu, WX Bei, X Lv, X Guo, ... JAMA network Open 4 (9), e2124721-e2124721, 2021 | 28 | 2021 |
| A randomized controlled trial comparing two different schedules for cisplatin treatment in patients with locoregionally advanced nasopharyngeal cancer WX Xia, X Lv, H Liang, GY Liu, R Sun, Q Zeng, SW Li, HY Mo, F Han, ... Clinical cancer research 27 (15), 4186-4194, 2021 | 25 | 2021 |
| A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy WZ Qiu, LR Ke, WX Xia, J Yang, YH Yu, H Liang, XJ Huang, GY Liu, WZ Li, ... PLoS One 12 (8), e0182963, 2017 | 20 | 2017 |
| The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort … HU Liang, X Lv, L Wang, YS Wu, R Sun, YF Ye, LR Ke, Q Yang, YH Yu, ... Therapeutic Advances in Medical Oncology 10, 1758835918782331, 2018 | 19 | 2018 |
| MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy … WZ Li, GY Liu, LF Lin, SH Lv, MY Qiang, X Lv, YS Wu, H Liang, LR Ke, ... Radiotherapy and Oncology 145, 101-108, 2020 | 17 | 2020 |
| A scoring system based on nutritional and inflammatory parameters to predict the efficacy of first-line chemotherapy and survival outcomes for de novo metastatic nasopharyngeal … WZ Li, X Hua, SH Lv, H Liang, GY Liu, N Lu, WX Bei, WX Xia, YQ Xiang Journal of Inflammation Research, 817-828, 2021 | 16 | 2021 |
| Benefit of chemotherapy in stage III nasopharyngeal carcinoma: analysis of the surveillance, epidemiology, and end results database ZF Xiang, DF Hu, HC Xiong, MY Li, ZC Zhang, ED Shen, WZ Li, YQ Xiang Oral Oncology 117, 105284, 2021 | 15 | 2021 |
weixiong xiasun yat-sen university cancer centerVerified email at sysucc.org.cn